The Oncology Institute, Inc. (TOIIW)
USD 0.02
(-17.27%)
USD 0.02
(-17.27%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 324.23 Million USD | 28.42% |
| 2022 | 252.48 Million USD | 24.37% |
| 2021 | 203 Million USD | 8.26% |
| 2020 | 187.51 Million USD | 20.66% |
| 2019 | 155.4 Million USD | 37.33% |
| 2018 | 113.16 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 98.57 Million USD | 4.13% |
| 2024 Q1 | 94.66 Million USD | 10.35% |
| 2023 Q4 | 85.78 Million USD | 4.57% |
| 2023 Q1 | 76.19 Million USD | 6.68% |
| 2023 FY | 324.23 Million USD | 28.42% |
| 2023 Q2 | 80.22 Million USD | 5.29% |
| 2023 Q3 | 82.03 Million USD | 2.26% |
| 2022 Q4 | 71.42 Million USD | 9.92% |
| 2022 FY | 252.48 Million USD | 24.37% |
| 2022 Q3 | 64.97 Million USD | 6.66% |
| 2022 Q2 | 60.92 Million USD | 10.44% |
| 2022 Q1 | 55.16 Million USD | 5.46% |
| 2021 Q1 | 48.58 Million USD | -74.09% |
| 2021 Q4 | 52.3 Million USD | 0.06% |
| 2021 Q3 | 52.27 Million USD | 4.88% |
| 2021 Q2 | 49.84 Million USD | 2.6% |
| 2021 FY | 203 Million USD | 8.26% |
| 2020 Q2 | 47.27 Million USD | 7.4% |
| 2020 Q1 | 44.01 Million USD | 0.0% |
| 2020 FY | 187.51 Million USD | 20.66% |
| 2020 Q4 | 187.51 Million USD | 296.86% |
| 2020 Q3 | 47.24 Million USD | -0.06% |
| 2019 FY | 155.4 Million USD | 37.33% |
| 2018 FY | 113.16 Million USD | 0.0% |
| 2018 Q4 | 37.35 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 88.929% |
| Addus HomeCare Corporation | 1.05 Billion USD | 69.372% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -65.498% |
| Amedisys, Inc. | 2.23 Billion USD | 85.502% |
| American Oncology Network, Inc. | 1.27 Billion USD | 74.653% |
| Astrana Health, Inc. | 1.38 Billion USD | 76.617% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 82.892% |
| IMAC Holdings, Inc. | 5.19 Million USD | -6138.965% |
| biote Corp. | 185.36 Million USD | -74.924% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -934.463% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 83.946% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 48.063% |
| The Ensign Group, Inc. | 3.72 Billion USD | 91.306% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 80.601% |
| InnovAge Holding Corp. | 763.85 Million USD | 57.552% |
| Assure Holdings Corp. | 255 Thousand USD | -127052.549% |
| The Joint Corp. | 117.69 Million USD | -175.488% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 69.286% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -3030.168% |
| ModivCare Inc. | 2.75 Billion USD | 88.215% |
| NewGenIvf Group Limited | 5.13 Million USD | -6212.877% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -2479.053% |
| Option Care Health, Inc. | 4.3 Billion USD | 92.464% |
| P3 Health Partners Inc. | 1.26 Billion USD | 74.396% |
| P3 Health Partners Inc. | 1.26 Billion USD | 74.396% |
| The Pennant Group, Inc. | 544.89 Million USD | 40.495% |
| Surgery Partners, Inc. | 2.74 Billion USD | 88.181% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -5779.067% |
| Talkspace, Inc. | 150.04 Million USD | -116.095% |
| Talkspace, Inc. | 150.04 Million USD | -116.095% |
| The Oncology Institute, Inc. | 324.23 Million USD | 0.0% |